Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading?
Hui Liu, Kangdong Liu, Zigang Dong
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk
Mohammad Ahmad, Louis‐Bastien Weiswald, Laurent Poulain, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 60
Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK
Ruth Nussinov, Bengi Ruken Yavuz, M. Kaan Arici, et al.
Biophysical Reviews (2023) Vol. 15, Iss. 2, pp. 163-181
Open Access | Times Cited: 37
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome
Felix Broghammer, Irina Korovina, Mahesh Gouda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance
Marilina García-Aranda, Teresa Téllez, Lauraine McKenna, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2255-2255
Open Access | Times Cited: 24
The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma
Yi Ma, Mehrdad Nikfarjam, Hong He
Cancer Letters (2022) Vol. 548, pp. 215868-215868
Closed Access | Times Cited: 20
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma
Helena Sorger, Saptaswa Dey, Pablo Vieyra-Garcia, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 12
Open Access | Times Cited: 20
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities
Penglei Wang, Kyle Vaughn Laster, Xuechao Jia, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Genome analysis uncovers an inverse correlation between alterations in P21‐activated kinases and patient survival across multiple cancer types
Josh N. Vo, L.B. La, Abraham Anderson, et al.
Physiological Reports (2025) Vol. 13, Iss. 1
Open Access
The Important Role of p21-Activated Kinases in Pancreatic Exocrine Function
Irene Ramos-Álvarez, Robert T. Jensen
Biology (2025) Vol. 14, Iss. 2, pp. 113-113
Open Access
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14
Zhi‐Man Zhu, Fu‐Chun Huo, Ce Shi, et al.
International Journal of Biological Macromolecules (2025) Vol. 309, pp. 142880-142880
Closed Access
Established and emerging roles of protein kinases in regulating primary sensory neurons in injury-and inflammation-associated pain
David Zimmermann, Michaela Kress, I. Nagy
Expert Opinion on Therapeutic Targets (2025)
Open Access
FRAX486, a PAK inhibitor, overcomes ABCB1-mediated multidrug resistance in breast cancer cells.
Meng Zhang, Xiao-Qi Zeng, Meiling She, et al.
PubMed (2024) Vol. 57, pp. e13357-e13357
Closed Access | Times Cited: 3
Rho family GTPase signaling through type II p21-activated kinases
Ashwin K. Chetty, Byung Hak Ha, Titus J. Boggon
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 15
Development and Utility of a PAK1-Selective Degrader
Hoi-Yee Chow, Sofiia Karchugina, Brian J. Groendyke, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 23, pp. 15627-15641
Open Access | Times Cited: 15
The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: From genotype to phenotype
Manon Dobrigna, Sandrine Poëa‐Guyon, Véronique Rousseau, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily
Marcel Rak, Roberta Tesch, Lena M. Berger, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115347-115347
Open Access | Times Cited: 9
Mechanoregulation of Metastasis beyond the Matrix
Ekrem Emrah Er, María Tello‐Lafoz, Morgan Huse
Cancer Research (2022) Vol. 82, Iss. 19, pp. 3409-3419
Open Access | Times Cited: 11
Single-cell transcriptomics identifies a p21-activated kinase important for survival of the zoonotic parasiteFasciola hepatica
Oliver Puckelwaldt, Svenja Gramberg, Sagar Ajmera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
P-21 Activated Kinases in Liver Disorders
Xun Qiu, Hanzhi Xu, Kai Wang, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 551-551
Open Access | Times Cited: 6
Restored autophagy is protective against PAK3-induced cardiac dysfunction
Andrea Ruiz‐Velasco, Rida Raja, Xinyi Chen, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106970-106970
Open Access | Times Cited: 5
The Marine Natural Compound Dragmacidin D Selectively Induces Apoptosis in Triple-Negative Breast Cancer Spheroids
Esther A. Guzmán, Tara A. Peterson, Amy E. Wright
Marine Drugs (2023) Vol. 21, Iss. 12, pp. 642-642
Open Access | Times Cited: 5
p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond
Xiaodong Li, Feng Li
Cancers (2022) Vol. 14, Iss. 19, pp. 4736-4736
Open Access | Times Cited: 8
Minor Kinases with Major Roles in Cytokinesis Regulation
Stefano Sechi, Roberto Piergentili, Maria Grazia Giansanti
Cells (2022) Vol. 11, Iss. 22, pp. 3639-3639
Open Access | Times Cited: 6
The miR‐29 family members induce glioblastoma cell apoptosis by targeting cell division cycle 42 in a p53‐dependent manner
Cuijuan Shi, Wenjun Luo, Cuiyun Sun, et al.
European Journal of Clinical Investigation (2023) Vol. 53, Iss. 6
Closed Access | Times Cited: 3
Targeting P21-activated kinase suppresses proliferation and enhances chemosensitivity in T-cell lymphoblastic lymphoma
Ning Su, Fang Yu, Xu Chen, et al.
Blood Science (2023) Vol. 5, Iss. 4, pp. 249-257
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top